经皮冠状动脉介入治疗的前景：药物洗脱支架作为监管审查的一个范例 - Suppr

Percutaneous coronary intervention in perspective: drug-eluting stents as a model for regulatory review.

作者信息

Kandzari David E, Farb Andrew, Boam Ashley B

机构信息

Division of Cardiovascular Disease, Scripps Clinic, Maildrop S1056, 10666 North Torrey Pines Rd, La Jolla, CA 92037, USA.

出版信息

Circ Cardiovasc Interv. 2009 Dec;2(6):574-9. doi: 10.1161/CIRCINTERVENTIONS.109.871996.

DOI:10.1161/CIRCINTERVENTIONS.109.871996

PMID:20031776

Abstract

摘要

相似文献

Percutaneous coronary intervention in perspective: drug-eluting stents as a model for regulatory review.

Circ Cardiovasc Interv. 2009 Dec;2(6):574-9. doi: 10.1161/CIRCINTERVENTIONS.109.871996.

Off-label use and the spectre of drug-eluting stent thrombosis.

Circ Cardiovasc Interv. 2009 Aug;2(4):273-6. doi: 10.1161/CIRCINTERVENTIONS.109.891218.

The off- versus on-label use of medical devices in interventional cardiovascular medicine: clarifying the ambiguity between regulatory labeling and clinical decision-making, Part 1: PCI.

Catheter Cardiovasc Interv. 2008 Oct 1;72(4):500-4. doi: 10.1002/ccd.21697.

Recent progress in percutaneous coronary intervention: evolution of the drug-eluting stents, focus on the XIENCE V drug-eluting stent.

Coron Artery Dis. 2010 Jan;21(1):46-56. doi: 10.1097/MCA.0b013e328333f550.

Clopidogrel use in diabetic patients with new stents.

Cardiovasc J Afr. 2008 Jul-Aug;19(4):232.

The turmoil around the drug-eluting stents.

Scand Cardiovasc J. 2007 Jun;41(3):131-2. doi: 10.1080/14017430701308851.

Drug-eluting stent thrombosis in routine clinical practice: two-year outcomes and predictors from the TAXUS ARRIVE registries.

Circ Cardiovasc Interv. 2009 Aug;2(4):285-93. doi: 10.1161/CIRCINTERVENTIONS.109.852178.109.852178. Epub 2009 Jul 22.

Drug-eluting stent fracture and acute coronary syndrome.

Cardiovasc Revasc Med. 2009 Jul-Sep;10(3):166-71. doi: 10.1016/j.carrev.2009.02.003.

Antiplatelet therapy in percutaneous coronary intervention: a critical review of the 2007 AHA/ACC/SCAI guidelines and beyond.

Catheter Cardiovasc Interv. 2009 Oct 1;74(4):579-97. doi: 10.1002/ccd.22021.

Meeting report ESC forum on drug eluting stents, European Heart House, Nice, 27-28 September 2007.

EuroIntervention. 2009 Jan;4(4):427-36.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Percutaneous coronary intervention in perspective: drug-eluting stents as a model for regulatory review.

Circ Cardiovasc Interv. 2009 Dec;2(6):574-9. doi: 10.1161/CIRCINTERVENTIONS.109.871996.

Off-label use and the spectre of drug-eluting stent thrombosis.

Circ Cardiovasc Interv. 2009 Aug;2(4):273-6. doi: 10.1161/CIRCINTERVENTIONS.109.891218.

The off- versus on-label use of medical devices in interventional cardiovascular medicine: clarifying the ambiguity between regulatory labeling and clinical decision-making, Part 1: PCI.

Catheter Cardiovasc Interv. 2008 Oct 1;72(4):500-4. doi: 10.1002/ccd.21697.

Recent progress in percutaneous coronary intervention: evolution of the drug-eluting stents, focus on the XIENCE V drug-eluting stent.

Coron Artery Dis. 2010 Jan;21(1):46-56. doi: 10.1097/MCA.0b013e328333f550.

Clopidogrel use in diabetic patients with new stents.

Cardiovasc J Afr. 2008 Jul-Aug;19(4):232.

The turmoil around the drug-eluting stents.

Scand Cardiovasc J. 2007 Jun;41(3):131-2. doi: 10.1080/14017430701308851.

Drug-eluting stent thrombosis in routine clinical practice: two-year outcomes and predictors from the TAXUS ARRIVE registries.

Circ Cardiovasc Interv. 2009 Aug;2(4):285-93. doi: 10.1161/CIRCINTERVENTIONS.109.852178.109.852178. Epub 2009 Jul 22.

Drug-eluting stent fracture and acute coronary syndrome.

Cardiovasc Revasc Med. 2009 Jul-Sep;10(3):166-71. doi: 10.1016/j.carrev.2009.02.003.

Antiplatelet therapy in percutaneous coronary intervention: a critical review of the 2007 AHA/ACC/SCAI guidelines and beyond.

Catheter Cardiovasc Interv. 2009 Oct 1;74(4):579-97. doi: 10.1002/ccd.22021.

Meeting report ESC forum on drug eluting stents, European Heart House, Nice, 27-28 September 2007.

EuroIntervention. 2009 Jan;4(4):427-36.

Percutaneous coronary intervention in perspective: drug-eluting stents as a model for regulatory review.

作者信息

Kandzari David E, Farb Andrew, Boam Ashley B

机构信息

Division of Cardiovascular Disease, Scripps Clinic, Maildrop S1056, 10666 North Torrey Pines Rd, La Jolla, CA 92037, USA.

出版信息

Circ Cardiovasc Interv. 2009 Dec;2(6):574-9. doi: 10.1161/CIRCINTERVENTIONS.109.871996.

DOI:10.1161/CIRCINTERVENTIONS.109.871996

PMID:20031776

Abstract

摘要

Percutaneous coronary intervention in perspective: drug-eluting stents as a model for regulatory review.

作者信息

机构信息

出版信息

相似文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

Percutaneous coronary intervention in perspective: drug-eluting stents as a model for regulatory review.

作者信息

机构信息

出版信息